• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Stem Cell: Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells

tetano

Editor, Senior Moderator
Brief Report

[h=1][/h] [h=1]Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells[/h] Tomasz J. Nowakowski[SUP]3[/SUP]
, Alex A. Pollen[SUP]3[/SUP]
, Elizabeth Di Lullo
, Carmen Sandoval-Espinosa
, Marina Bershteyn
, Arnold R. Kriegstein
article_notepad.gif

[SUP]3[/SUP]Co-first author

Publication stage: In Press Corrected Proof

DOI: http://dx.doi.org/10.1016/j.stem.2016.03.012

[h=2]Main Text[/h] In February 2016, the World Health Organization declared the 2015 outbreak of the Zika virus (ZIKV) in Central and South America a global health emergency (Heymann et al., 2016) following a strong correlation between cases of ZIKV infection and a dramatic increase in microcephaly cases in Brazil (Oliveira Melo et al., 2016, Schuler-Faccini et al., 2016). Subsequent reports have now established the ability of ZIKV to cross the human fetal-placental barrier to infect the developing central nervous system (Calvet et al., 2016, Martines et al., 2016, Mlakar et al., 2016). The neurotropism and neurovirulence of ZIKV has been appreciated in model systems since the earliest description of the virus (Bell et al., 1971, Dick, 1952, Dick et al., 1952), but it has only recently been described in human neural stem and progenitor cells using in vitro systems (Tang et al., 2016; P.P. Garc?z, E.C. Loiola, R.M. da Costa, L.M. Higa, P. Trindade, R. Delvecchio, J.M. Nascimento, R. Brindeiro, A. Tanuri, and S.K. Rehen, 2016, PeerJ, preprint). Although pathology data is currently limited, the first imaging studies and cases with confirmed ZIKV infection in the prenatal brain showed devastating consequences, including severe microcephaly, lissencephaly, hydrocephaly, necrosis, periventricular and cortical calcification, diffuse astrogliosis, and activated microglia (Mlakar et al., 2016, Schuler-Faccini et al., 2016). The findings of massive cell death and necrosis reflect a far more destructive process than occurs in many genetic forms of microcephaly.

full text

http://www.cell.com/cell-stem-cell/fulltext/S1934-5909(16)00118-1
 
Back
Top Bottom